This review highlights important studies and the latest treatment modalities available for stroke prevention in patients with non-valvular atrial fibrillation.
Summarizes evolving options for stroke prevention in non-valvular AF; leaves open optimal selection and integration pending prospective validation.
Non-valvular atrial fibrillation is a common and from a neurological perspective the most significant cardiac arrhythmia with a growing world-wide incidence. It also carries a significant associated morbidity and mortality, with cardioembolic strokes arguably being the most disabling sequelae. This brief review will highlight the important studies and the latest treatment modalities available for stroke prevention in patients with non-valvular atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Katsnelson et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: